Physical Medicine & Rehabilitation Doctors in King Of Prussia, PA Accepting Medicare

7 Physical Medicine & Rehabilitation doctors found. Showing 1 - 7

Dr. Marc Seth Effron, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 700 S Henderson Rd, Suite 308-c, King Of Prussia, PA 19406 Phone: 610-337-3111    Fax: 610-337-3506

Dr. Scott Davidoff, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 700 S Henderson Rd, Suite 308 C, King Of Prussia, PA 19406 Phone: 610-337-3111    Fax: 610-337-3506

Denis Patrick Rogers, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 700 S Henderson Rd, Ste 308c, King Of Prussia, PA 19406 Phone: 610-337-3111    Fax: 610-337-3506

Dr. Akbar Mostatab, M.D., D.P.H. Physical Medicine & Rehabilitation - Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 21510 Valley Forge Cir, King Of Prussia, PA 19406 Phone: 610-783-7134    Fax: 610-783-7134

Jeffery J Rowe, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 700 S Henderson Rd, Ste 308c, King Of Prussia, PA 19406 Phone: 610-337-3111    Fax: 610-337-3506

Roy Michael Lerman, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 700 S Henderson Rd, Suite 308c, King Of Prussia, PA 19406 Phone: 610-337-3111    Fax: 610-337-3506

Andrea E Feldman, PA Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 700 S Henderson Road, Suite 308c, King Of Prussia, PA 19406 Phone: 610-337-3111    Fax: 610-337-3506

News Archive

Rural residents of Utah less likely to follow colorectal cancer screening recommendations

People who reside in rural areas of Utah are less likely to follow colorectal cancer (CRC) screening recommendations than their urban counterparts, according to researchers from Huntsman Cancer Institute (HCI) at the University of Utah.

Mayo Clinic scientists say JAK inhibitors may help treat patients with myelofibrosis

Two janus kinase (JAK) inhibitors are substantially improving treatment of myelofibrosis in patients, say Mayo Clinic researchers who are presenting results of several clinical trials at the 52nd annual meeting of the American Society of Hematology (ASH) Dec. 4 in Orlando.

SQI Diagnostics gets FDA clearance to market Celiac Panel in the US

SQI Diagnostics Inc. today announced that it has received notice that the United States Food and Drug Administration has cleared the Company to market its proprietary Celiac Panel in the United States (US).

FDA approves Allergan's sNDA to update label for TEFLARO (ceftaroline fosamil)

Allergan plc today announced the U.S. Food and Drug Administration has approved the company's supplemental new drug application (sNDA) to update the label for TEFLARO (ceftaroline fosamil) for the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).

Idiopathic intracranial hypertension leads to vision loss more often in blacks

Black people are more likely to lose vision as a result of idiopathic intracranial hypertension, or increased pressure in the brain, according to a study published in the March 11, 2008, issue of Neurology, the medical journal of the American Academy of Neurology.

Read more Medical News

› Verified 3 days ago